With its stock down 25% over the past three months, it is easy to disregard Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336). But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. In this article, we decided to focus on Sunshine Guojian Pharmaceutical (Shanghai)’s ROE.
ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.
See our latest analysis for Sunshine Guojian Pharmaceutical (Shanghai)
How Do You Calculate Return On Equity?
ROE can be calculated by using the formula:
Return on Equity = Net Profit (from continuing operations)…
